Authors: Ikuta, Y Okugawa, T Furugen, R Nagata, Y Takahashi, Y Wang, LJ Ikeda, H Watanabe, M Imai, S Shiku, H

Citation: Y. Ikuta et al., A HER2/NEU-derived peptide, a K-d-restricted murine tumor rejection antigen, induces HER2-specific HLA-A2402-restricted CD8(+) cytotoxic T lymphocytes, INT J CANC, 87(4), 2000, pp. 553-558

Authors: Okugawa, T Ikuta, Y Takahashi, Y Obata, H Tanida, K Watanabe, M Imai, S Furugen, R Nagata, Y Toyoda, N Shiku, H

Citation: T. Okugawa et al., A novel human HER2-derived peptide homologous to the mouse K-d-restricted tumor rejection antigen can induce HLA-A24-restricted cytotoxic T lymphocytes in ovarian cancer patients and healthy individuals, EUR J IMMUN, 30(11), 2000, pp. 3338-3346

Authors: Zhao, JM Furukawa, K Fukumoto, S Okada, M Furugen, R Miyazaki, H Takamiya, K Aizawa, S Shiku, H Matsuyama, T Furukawa, K

Citation: Jm. Zhao et al., Attenuation of interleukin 2 signal in the spleen cells of complex ganglioside-lacking mice, J BIOL CHEM, 274(20), 1999, pp. 13744-13747